---
title: "The GLP-1 Problem No One Is Talking About: A New Metabolic Approach"
type: "Podcast"
date: "2026-11-16"
updated: "2026-11-16"
description: "Dr. Kara Fitzgerald and guests discuss the trade-offs of GLP-1 therapy and look at SiPore® and the SHINE trial as a gut-local approach to metabolic health."
url: "https://sipore.com/insights/the-glp-1-problem-no-one-is-talking-about-a-new-metabolic-approach"
canonical: "https://sipore.com/insights/the-glp-1-problem-no-one-is-talking-about-a-new-metabolic-approach"
markdown_url: "https://sipore.com/insights/the-glp-1-problem-no-one-is-talking-about-a-new-metabolic-approach.md"
site: "SiPore"
publisher: "SiPore Technologies (Sigrid Therapeutics AB)"
contact: "contact@sipore.com"
language: "en"
topics:
  - "GLP-1"
  - "Metabolic health"
  - "Gut-local mechanisms"
  - "SHINE trial"
show: "Dr. Kara Fitzgerald | New Frontiers in Functional Medicine"
featuring: "Dr. Sanjay Bhojraj, Dr. Alexis Gonzales"
---

# The GLP-1 Problem No One Is Talking About: A New Metabolic Approach

*Podcast · Nov 16, 2026*

> Dr. Kara Fitzgerald and guests discuss the trade-offs of GLP-1 therapy and look at SiPore® and the SHINE trial as a gut-local approach to metabolic health.

## Listen

- [Apple Podcasts](https://podcasts.apple.com/us/podcast/the-glp-1-problem-no-one-is-talking-about-a/id1103271110?i=1000784597016)

## Related articles

- [Bigger Waist Size? Higher Blood Pressure? Metabolic Syndrome and Preventative Health with Sigrid Therapeutics](https://sipore.com/insights/bigger-waist-size-higher-blood-pressure-metabolic-syndrome-and-preventative-heal.md) — Podcast, 2026-11-16
- [The Food Industry Insider Who Left to Fix Your Metabolic Health](https://sipore.com/insights/the-food-industry-insider-who-left-to-fix-your-metabolic-health.md) — Podcast, 2026-11-16

## How to cite

SiPore Technologies (Sigrid Therapeutics AB). “The GLP-1 Problem No One Is Talking About: A New Metabolic Approach”. SiPore, 2026-11-16. https://sipore.com/insights/the-glp-1-problem-no-one-is-talking-about-a-new-metabolic-approach (accessed <date>).

Use the trademarks as written: SiPore®, Carb Fence™. For the SHINE trial, cite the peer-reviewed publication in *eClinicalMedicine* (The Lancet Discovery Science, 2026) rather than this page.

## Company & contact

- **Company:** SiPore Technologies — legal entity Sigrid Therapeutics AB (Swedish org.nr [556958-3023](https://www.allabolag.se/foretag/sigrid-therapeutics-ab/sundbyberg/forskning/2K3ZHRJI5YE3M))
- **Stockholm headquarters:** Vasagatan 14A, 172 61 Sundbyberg, Sweden ([map](https://www.google.com/maps/search/?api=1&query=Vasagatan%2014A%2C%20172%2061%20Sundbyberg%2C%20Sweden))
- **General enquiries:** [contact@sipore.com](mailto:contact@sipore.com)
- **Partnerships & licensing:** [partnerships@sipore.com](mailto:partnerships@sipore.com)
- **Origin:** Founded in Stockholm, Sweden
- **Taglines:** “The meal companion for modern food.” · “Same meal. Less impact.” · “Scandinavian science. Global impact.” · “Precision science for the modern meal.”
- **About:** SiPore® is a patented meal-companion technology designed to reduce the impact of modern meals at the level of digestion.

**Our sites** — all sites owned and operated by Sigrid Therapeutics AB:

- [SiPore.com](https://www.sipore.com/): Technology, science & partnerships
- [SiPorePro.com](https://www.siporepro.com/): Practitioner products & professional resources
- [SigridLife.com](https://sigridlife.com/): SIGRID consumer products
- [SigridStabiliser.se](https://sigridstabiliser.se/): SIGRID Sweden

---
[View on site](https://sipore.com/insights/the-glp-1-problem-no-one-is-talking-about-a-new-metabolic-approach) · [All insights](https://sipore.com/insights.md) · [Site index for agents (llms.txt)](https://sipore.com/llms.txt)
